002390 Stock Overview
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Guizhou Xinbang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.14 |
52 Week High | CN¥5.00 |
52 Week Low | CN¥3.14 |
Beta | 0.47 |
11 Month Change | -2.48% |
3 Month Change | -14.91% |
1 Year Change | -28.64% |
33 Year Change | -67.26% |
5 Year Change | -42.28% |
Change since IPO | -40.33% |
Recent News & Updates
Investors Aren't Buying Guizhou Xinbang Pharmaceutical Co., Ltd.'s (SZSE:002390) Earnings
Jun 26These 4 Measures Indicate That Guizhou Xinbang Pharmaceutical (SZSE:002390) Is Using Debt Safely
May 24Shareholder Returns
002390 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -7.4% | -2.2% | -1.1% |
1Y | -28.6% | -8.8% | -17.4% |
Return vs Industry: 002390 underperformed the CN Pharmaceuticals industry which returned -8.8% over the past year.
Return vs Market: 002390 underperformed the CN Market which returned -17.4% over the past year.
Price Volatility
002390 volatility | |
---|---|
002390 Average Weekly Movement | 3.6% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.5% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 002390's share price has been volatile over the past 3 months.
Volatility Over Time: 002390's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 5,149 | Lingzhong Kong | www.xinbang.com |
Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medicine, gynecological treatment, and anti-infective drugs. It also operates in medical services; and pharmaceutical circulation business.
Guizhou Xinbang Pharmaceutical Co., Ltd. Fundamentals Summary
002390 fundamental statistics | |
---|---|
Market cap | CN¥6.06b |
Earnings (TTM) | CN¥293.11m |
Revenue (TTM) | CN¥6.44b |
20.4x
P/E Ratio0.9x
P/S RatioIs 002390 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002390 income statement (TTM) | |
---|---|
Revenue | CN¥6.44b |
Cost of Revenue | CN¥5.23b |
Gross Profit | CN¥1.21b |
Other Expenses | CN¥912.24m |
Earnings | CN¥293.11m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
Earnings per share (EPS) | 0.15 |
Gross Margin | 18.72% |
Net Profit Margin | 4.55% |
Debt/Equity Ratio | 10.0% |
How did 002390 perform over the long term?
See historical performance and comparison